Koninklijke Philips reported EUR6.32B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Abbott USD 29.45B 152M Sep/2026
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.42B 89M Sep/2026
Boston Scientific USD 10.79B 73M Jun/2026
Danaher USD 24.39B 759M Sep/2026
Demant DKK 13.13B 5.86B Jun/2026
Dexcom USD 1.3B 200K Jun/2026
Edwards Lifesciences USD 598.8M 100K Sep/2026
Fresenius EUR 10.51B 952M Sep/2026
General Electric Aerospace USD 16.99B 166M Sep/2026
Getinge SEK 9.09B 167M Jun/2026
Globus Medical USD 326K 54K Sep/2026
GN Store Nord DKK 7.72B 394M Sep/2026
Hitachi JPY 553.39B 9.55B Sep/2026
Idexx Laboratories USD 299.88M 14K Sep/2026
Insulet USD 943M 13.5M Sep/2026
Integra LifeSciences USD 1.83B 2.12M Sep/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 35.8B 1.55B Sep/2026
Koninklijke Philips EUR 6.32B 575M Jun/2026
Medtronic USD 25.62B 502M Jun/2026
Philips EUR 6.98B 669M Sep/2026
ResMed USD 399.42M 4.75M Jun/2026
Smith & Nephew USD 3.21B 85M Jun/2026
Steris USD 1.65B 100K Sep/2026
Stryker USD 14.18B 16M Sep/2026
Teleflex USD 1.53B 1.19B Sep/2026
Terumo JPY 246.97B 37.45B Sep/2026
Zimmer Biomet Holdings USD 6.22B 61M Sep/2026